top of page

The Healthcare Revolution has a name

Abarca Health and LucyRx completed their strategic combination and now operate under Healthcare Revolution Partners, bringing together the scale, technology, and track record to serve clients across commercial and government markets. 

9M+

Members Served

$15B

Drug Spend Managed

35+

Years of Combined  Experience

100%

Independent

Together, Abarca Health and LucyRx offer that alternative.

80%

market controlled by 3 PBMs, bundled, vertically integrated, limited flexibility¹

55%+

of pharmacy spend is specialty, for less than 2% of members²

37%

of PA requests lead to treatment abandonment³

30+

states now require PBM transparency, audit rights, and rebate pass-through⁴

Why now

The PBM market is at a breaking point.

Federal structural reforms are reshaping the landscape. Specialty drug costs and GLP-1s are driving double-digit trend. And the three largest PBMs — controlling more than 80% of the market — rely on vertically integrated, bundled models that limit flexibility and obscure economics.

The timing of this combination is intentional. Clients are demanding a different kind of PBM relationship — one that delivers more flexibility, true accountability, and sustainable affordability. Consumers and healthcare providers deserve a better experience. Depth and breadth of experience matters now. What's been missing is a fully independent alternative with the technology and expertise to deliver at a national scale, without compromise. That changes with this strategic combination.

What we bring together

Complementary strengths. One mission. 

Abarca Health and LucyRx share the same belief: a better way forward for prescription care. Together, the two companies form a truly modern, independent pharmacy benefit manager with the scale, technology, and track record to credibly serve commercial and government clients of any size.

Deliver Savings · Partner for Growth · Don't Play Games

✔ 20+ years of government-grade operational discipline


✔ Medicare, Medicaid, and commercial health plan expertise


✔ Modern PBM platform with Darwin — configurable, interoperable, API-based


✔ AI-powered decisioning through Darwin Healthcare Intelligence


✔ Auditable, transparent economics — no black boxes


✔ Virtual vertical integration, best-in-class services, à la carte

lucyLogo.png

Choice · Cost Transparency · Care

✔ Proven market expertise across all 50 states
 

✔ Connected Specialty Care Network with nationwide integration
 

✔ Formulary Marketplace — flexible, conflict-free formulary design
 

✔ LucyIQ intelligence platform for real-time clinical and pricing insights
 

✔ Care Guide patient support model with nurses and licensed pharmacists providing member-first care navigation 
 

✔ U.S.-based certified pharmacy technicians, next-day home delivery
 

✔ 4,000+ clients nationwide

Together, Abarca Health and LucyRx bring a modern, independent alternative at scale across commercial and government markets.

9 million+ members

60,000+ pharmacy partners

No owned pharmacies

No insurance affiliations.

No conflicts of interest.  

Business Continuity

Nothing changes for clients and members.

Business continuity is not just a message; it is our operating principle. Here is exactly what stays the same.

Same Teams

Your account managers, client success teams, and day-to-day contacts are unchanged. Same people. Same relationships. Same responsiveness.

Same Commitment

Both companies remain committed to delivering on their contractual commitments and client promises.

Same Operations

Day-to-day execution continues without disruption to service, data, or workflows. Both companies operate under their own brands.

Same Market Focus

LucyRx continues serving employers, labor organizations, and TPAs. Abarca continues leading in health plans and government programs.

Same Experience

Members continue using the same ID card, pharmacies, member portals, and support channels. Coverage and benefits are unchanged.

Same Leadership

Jason Borschow remains CEO of Abarca Health. David Blair remains CEO of LucyRx. Both now serve as Co-Chairs of Healthcare Revolution Partners.

What gets better

Over time, the combination expands what's possible.

While nothing changes today, our combined scale and capabilities will unlock new opportunities for clients, members, and partners over time.

01

Expanded clinical and specialty depth for all clients

Over time, the combination will create a path to broader capabilities. Abarca clients will gain access to LucyRx's Connected Specialty Care Network, comprehensive clinical programs, and the Care Guides patient support model. LucyRx clients will gain Abarca's government program expertise and Darwin Healthcare Intelligence platform.

02

Greater enterprise scale

Serving more than 9 million+ members gives the partners greater scale and operating capacity across commercial and government markets. That scale creates additional economic opportunity while client value continues to depend on the specific plan, solution, and economics.

03

Decision-grade intelligence at every touchpoint

Darwin Healthcare Intelligence, when deployed together, delivers real-time, AI-powered insights to clinical decision-making, pricing, and prior authorization, reducing friction for members and providers.

04

More pharmacy options and better member experience

Members will benefit from expanded retail, mail, and specialty pharmacy options, as well as enhanced clinical navigation for complex and chronic conditions.

Leadership

Two companies, one vision.

Leadership at both companies remains unchanged. Both brands operate as wholly owned subsidiaries of Healthcare Revolution Partners, with their existing CEOs continuing to lead and serving as Co-Chairs of Healthcare Revolution Partners.

David_Blair.png

"Leveraging our combined scale, technology, and track record, we are accelerating the healthcare revolution Abarca started more than 20 years ago. Together, we are delivering a trusted operating foundation, tailored customer experiences powered by best-in-class technology, and total-cost-of-care savings anchored in putting patients first."

David Blair

Chief Executive Officer, LucyRx

Jason-Borchow.png

"LucyRx shares our vision of making healthcare more seamless and personalized for everyone. We are leveraging LucyRx's clinical capabilities, Connected Specialty Care network, and expertise serving employers and labor groups nationwide to deepen our service offerings and accelerate our entry into new market segments."

Jason Borschow

Chief Executive Officer, Abarca Health

Frequently Asked Questions

Answers to what you're wondering.

Press & Media

For the press and media community

Access the official press release and connect with our communications teams.

Forbes

Abarca Health And LucyRx To Merge Into Alternative To Big Three PBMs

Jun 17, 2026

Go

Forbes

Merger Of Abarca And LucyRx May Not Be The Last PBM Deal This Year

Jun 18, 2026

Go

Managed Healthcare Executive

4 things to know about the Abarca/LucyRx merger

Jun 19, 2026

Go

Fierce Healthcare

As PBM industry shifts, LucyRx and Abarca Health merge to build scale

Jun 26, 2026

Go

MedCity

Abarca Health and LucyRx to Combine to Scale Independent PBM Model

Jun 22, 2026

Go

El Nuevo Día

Abarca Health crea nueva entidad en alianza con empresa en Maryland

Jul 06, 2026

Go

In the news

© 2026 Abarca Health and LucyRx. All rights reserved.

Privacy Notice

We use cookies and similar technologies to obtain user information, understand visitor engagement, and identify organizations and individuals who may be interested in our products and services.

When you interact with our website, we may collect personal and business-related information, including your name, job title, email address, phone number, company information, geographic location, and information about your interactions with our website. We may also use trusted third-party providers to supplement, verify, or enrich business contact information.

We may use this information for purposes including, but not limited to:

• Analyzing and improving our website, products, and services;
 • Understanding interest in our products and services;
 • Identifying potential business opportunities and prospective customers;
 • Contacting individuals and organizations regarding products, services, content, events, or other business-related communications that may be relevant to them; and
 • Supporting our sales, marketing, and business development activities.

By continuing to access or use this website, you acknowledge that you have read this notice and consent to the collection, use, and processing of information as described herein and in our Privacy Policy.

We do not sell or share personal information as those terms are defined under applicable California law.

For additional information, please review our Privacy Policy.

bottom of page